RA Capital co-leads a $125 million Series A for Ambros Therapeutics, advancing a chronic pain drug nearing pivotal testing.
Browsing: Market & Financials
Market trends, financial performance, quarterly results, and investment insights from global pharma and biotech companies.
Addition Therapeutics secures $100M to advance RNA-lipid nanoparticle gene therapies, backed by Gates Foundation.
Apple Tree Ventures files for bankruptcy amid a funding dispute with billionaire backer, affecting its startups and restructuring plans.
PsiThera, formerly Psivant Therapeutics, raises $47M for AI-designed oral drugs targeting immune conditions.
Hemophilia gene therapy faces market challenges despite innovation, with BioMarin, CSL, and Pfizer navigating barriers.
SciNeuro Pharmaceuticals funding of $53M aims to advance neurodegeneration drug development, supported by Arch Venture Partners.
FDA CDER leadership change sees Tracey Beth Høeg appointed as director, marking the fifth leadership shift in 2025.
Richard Pazdur retirement from FDA’s CDER marks a significant leadership change in 2025.
Novartis job cuts impact Swiss manufacturing, affecting hundreds of employees. Novo’s diabetes drug advances to Phase 3 trials. #Novartis #JobCuts #DiabetesDrug #PharmaSignal
Novartis job cuts affect hundreds in Swiss manufacturing, while Novo’s diabetes drug advances to Phase 3 trials.